![How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions | Journal of Nanobiotechnology | Full Text How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12951-021-01090-1/MediaObjects/12951_2021_1090_Fig5_HTML.png)
How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions | Journal of Nanobiotechnology | Full Text
![Tumor necrosis factor-α antagonists: Side effects and their management - Indian Journal of Dermatology, Venereology and Leprology Tumor necrosis factor-α antagonists: Side effects and their management - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2013/79/7/Images/ijdvl_2013_79_7_35_115526_b1.jpg)
Tumor necrosis factor-α antagonists: Side effects and their management - Indian Journal of Dermatology, Venereology and Leprology
![A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model | PNAS A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model | PNAS](https://www.pnas.org/cms/10.1073/pnas.2201137119/asset/14f4402b-4876-40ad-8d6d-79676320ea58/assets/images/large/pnas.2201137119fig01.jpg)
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model | PNAS
![VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis | 2 Minute Medicine VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2022/04/2MM-4.3.22._1_psoriasispersistence-scaled.jpg)
VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis | 2 Minute Medicine
![Frontiers | The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Frontiers | The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/814429/814429_Thumb_400.jpg)
Frontiers | The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis
![Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies | Semantic Scholar Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37a8a2d38b0b9085d23ce95f9aa6d1e564bb1e1d/6-Table1-1.png)
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies | Semantic Scholar
![The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00296-022-05136-x/MediaObjects/296_2022_5136_Fig1_HTML.png)
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International
![Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/411537e7-48c3-4c14-87d9-02540e60943d/gr1.jpg)